Imeik Technology Development Co Ltd
SZSE:300896
Intrinsic Value
Imeik Technology Development Co., Ltd. engages in the research, development, and transformation of biomedical materials, with a focus on recombinant proteins and peptides. [ Read More ]
The intrinsic value of one
Imeik Technology Development Co Ltd
stock under the Base Case scenario is
239.71
CNY.
Compared to the current market price of 279.5 CNY,
Imeik Technology Development Co Ltd
is
Overvalued by 14%.
Imeik Technology Development Co Ltd's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
Imeik Technology Development Co Ltd or that its price is influenced by factors unrelated to fundamentals.
Imeik Technology Development Co Ltd's market capitalization is 60.5B CNY.
Imeik Technology Development Co Ltd stock price is 279.5 CNY.
Imeik Technology Development Co Ltd stock (239.71 CNY) is 14% less than its price (279.5 CNY).
Imeik Technology Development Co Ltd stock price (279.5 CNY) is 2% less than its DCF Value (285.13 CNY). Open DCF Valuation
Imeik Technology Development Co Ltd stock (194.28 CNY) is 30% less than its price (279.5 CNY). Open Relative Valuation
Imeik Technology Development Co Ltd has upside potential of 84% compared to the average analyst price target.
Open Wall St Estimates
Imeik Technology Development Co Ltd's Revenue has grown by an exceptional 32% over the past 12 months.
Imeik Technology Development Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 24%.
Imeik Technology Development Co Ltd's ROE (Return on Equity) has significantly increased in the last 3 years from 13% to 24%.
Imeik Technology Development Co Ltd has positive three-year average ROE (Return on Equity): 21%. The company is efficient at transforming stockholders' equity into net income.
Imeik Technology Development Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 129% to 57%.
Imeik Technology Development Co Ltd's Revenue is forecast to grow at a rate of 40% per year over the next 3 years.
Imeik Technology Development Co Ltd has positive Operating Income for the last twelve months.
Imeik Technology Development Co Ltd has positive Net Income for the last twelve months.
Imeik Technology Development Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 57%.
Imeik Technology Development Co Ltd has positive Gross Profit for the last twelve months.
Imeik Technology Development Co Ltd has positive Free Cash Flow for the last twelve months.
Imeik Technology Development Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.01.
Imeik Technology Development Co Ltd has very high three-year average ROIC (Return on Invested Capital): 96%. The company is very efficient at using invested capital to generate operating income.
Imeik Technology Development Co Ltd's short-term assets (4B CNY) exceed its short-term liabilties (198m CNY).
Imeik Technology Development Co Ltd's long-term assets (7B CNY) exceed its long-term liabilties (431m CNY).
Imeik Technology Development Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (4B CNY) than debt (53m CNY).
Imeik Technology Development Co Ltd's Altman Z-Score is very high and is equal to 168.98.
Valuation Backtest
Imeik Technology Development Co Ltd
Run backtest to discover the historical profit from buying and selling
Imeik Technology Development Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Imeik Technology Development Co Ltd
Balance Sheet Decomposition
Imeik Technology Development Co Ltd
| Current Assets | 4.1B |
| Cash & Short-Term Investments | 3.8B |
| Receivables | 144.6m |
| Other Current Assets | 158.5m |
| Non-Current Assets | 2.6B |
| Long-Term Investments | 1.8B |
| PP&E | 274.2m |
| Intangibles | 359.7m |
| Other Non-Current Assets | 95.5m |
| Current Liabilities | 197.8m |
| Accounts Payable | 23.6m |
| Accrued Liabilities | 59.3m |
| Other Current Liabilities | 115m |
| Non-Current Liabilities | 233.2m |
| Long-Term Debt | 53.4m |
| Other Non-Current Liabilities | 179.9m |
Earnings Waterfall
Imeik Technology Development Co Ltd
|
Revenue
|
2.1B
CNY
|
|
Cost of Revenue
|
-116m
CNY
|
|
Gross Profit
|
2B
CNY
|
|
Operating Expenses
|
-502.9m
CNY
|
|
Operating Income
|
1.5B
CNY
|
|
Other Expenses
|
-121.8m
CNY
|
|
Net Income
|
1.4B
CNY
|
Free Cash Flow Analysis
Imeik Technology Development Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Imeik Technology Development Co Ltd's profitability score is 80/100. The higher the profitability score, the more profitable the company is.
Score
Imeik Technology Development Co Ltd's profitability score is 80/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Imeik Technology Development Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Imeik Technology Development Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Imeik Technology Development Co Ltd
According to Wall Street analysts, the average 1-year price target for
Imeik Technology Development Co Ltd
is 515.03 CNY
with a low forecast of 380.77 CNY and a high forecast of 827.4 CNY.
Shareholder Return
Price
Imeik Technology Development Co Ltd
| Average Annual Return | 49.5% |
| Standard Deviation of Annual Returns | 52.41% |
| Max Drawdown | -67% |
| Market Capitalization | 63B CNY |
| Shares Outstanding | 215 194 126 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Imeik Technology Development Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Imeik Technology Development Co., Ltd. engages in the research, development, and transformation of biomedical materials, with a focus on recombinant proteins and peptides. The company is headquartered in Beijing, Beijing and currently employs 507 full-time employees. The company went IPO on 2020-09-28. The firm focuses on the development and transformation of biomedical materials, and is committed to the development of biomedicine such as recombinant proteins and peptides. The firm has realized the industrialization of injection-type sodium hyaluronate series products and polydioxanone facial implants, and has established a product technology transformation platform for biomedical materials such as medical chitosan and polylactic acid. The firm's self-developed products are mainly aimed at the repair of fold skin on the face and neck. The clinical applications of its products cover medical cosmetology, surgical repair, and treatment of metabolic diseases. The firm mainly conducts its businesses in the China market.
Contact
IPO
Employees
Officers
The intrinsic value of one
Imeik Technology Development Co Ltd
stock under the Base Case scenario is
239.71
CNY.
Compared to the current market price of 279.5 CNY,
Imeik Technology Development Co Ltd
is
Overvalued by 14%.
You don't have any saved screeners yet
